Clinical trial
Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer
NCT02838381 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- June 11, 2024
- Enrollment
- 553 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic cancer